Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for Cyclerion Therapeutics (CYCN) over the last 3 years, with Q3 2025 value amounting to $30000.0.

  • Cyclerion Therapeutics' Other Non Operating Income fell 2857.14% to $30000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $117000.0, marking a year-over-year decrease of 5836.3%. This contributed to the annual value of $208000.0 for FY2024, which is 4189.94% down from last year.
  • As of Q3 2025, Cyclerion Therapeutics' Other Non Operating Income stood at $30000.0, which was down 2857.14% from $31000.0 recorded in Q2 2025.
  • In the past 5 years, Cyclerion Therapeutics' Other Non Operating Income ranged from a high of $107000.0 in Q3 2023 and a low of $28000.0 during Q4 2024
  • Its 3-year average for Other Non Operating Income is $56111.1, with a median of $42000.0 in 2024.
  • Per our database at Business Quant, Cyclerion Therapeutics' Other Non Operating Income crashed by 7227.72% in 2024 and then tumbled by 2857.14% in 2025.
  • Quarter analysis of 3 years shows Cyclerion Therapeutics' Other Non Operating Income stood at $101000.0 in 2023, then plummeted by 72.28% to $28000.0 in 2024, then grew by 7.14% to $30000.0 in 2025.
  • Its Other Non Operating Income was $30000.0 in Q3 2025, compared to $31000.0 in Q2 2025 and $28000.0 in Q1 2025.